Ownership

Hans Hull - Chief Business Officer at Pliant Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Business Officer
Stock Symbol: PLRX on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Hans Hull - trading volume in the past year for Pliant Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-19.7K	100%	$14.38	-$283K
Net	-19.7K	-100%		-$283K

Holdings reported by Hans Hull for Pliant Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	227K	$2.63M	$11.56	Jul 10, 2024	Direct
Common Stock	14K	$162K	$11.56	Jul 10, 2024	Indirect
Common Stock (Right to Buy)	31.4K	$65.2K	$2.08	Aug 4, 2023	Direct	Common Stock
Stock Option (Right to Buy)	63K			Jan 23, 2024	Direct	Common Stock

Transactions reported by Hans Hull for Pliant Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.